Sort
23,748 grants matching “melanoma”
Nuclear receptors: action, functions, and roles in disease
$1,247,722Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$1,247,511Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Regulation of Cutaneous Accessory Cell Activity in Health and Disease
$1,244,611Mark Udey · Clinical Sciences · Z01 · FY2007 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$1,243,881Beverly A. Mock · Basic Sciences · Z01 · FY2007 · CA
Area C: Genome-wide identification and targeting of resistance to cancer therapy
$1,242,934J. Silvio Gutkind · University Of California, San Diego · R33 · FY2017 · CA
Biospecimen Unit
$1,241,085Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2023 · CA
Chemoprevention of Skin Cancer Program Project
$1,240,584David S Alberts · University Of Arizona · P01 · FY2013 · CA
NHGRI/DIR Technology Transfer Program
$1,240,530Eric Green · National Human Genome Research Institute · Z01 · FY2008 · HG
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$1,239,509Ashish Ranjan · Ut Southwestern Medical Center · R37 · FY2025 · CA
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,239,425Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Translational Applications of mda-7/IL-24 in Cancer
$1,239,416Paul B Fisher · Columbia University Health Sciences · P01 · FY2006 · CA
An integrated translational approach to overcome drug resistance
$1,239,225Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2019 · CA
Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation
$1,238,908Jay Kenneth Fisher · Redbud Labs, Inc. · R44 · FY2024 · GM
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,237,901Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Sister Study TASK ORDER 02: CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY
$1,237,859Dale Sandler · Social And Scientific Systems, Inc. · N01 · FY2020 · ES
Regulation of Ras-Dependent Signal Transduction Pathways
$1,237,028Deborah K Morrison · Basic Sciences · Z01 · FY2007 · CA
Novel SCD1 inhibitors for treatment of cancer
$1,236,819John A Copland · Modulation Therapeutics, Inc. · R42 · FY2019 · CA
Surgery Branch Cell Prep Core
$1,236,025John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Cell Production Core Facility
$1,236,025Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Translational Applications of mda-7/IL-24 in Cancer
$1,235,688Paul B Fisher · Columbia University Health Sciences · P01 · FY2007 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,232,770Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,232,770Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Replication of Human Endogenous Retroviruses in Modern Humans
$1,231,806David Michael Markovitz · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
NYU Melanoma SPORE
$1,230,080Iman Osman · New York University School Of Medicine · P50 · FY2025 · CA
Directing Tumor-specific T cells to Tumors
$1,229,591Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · CA